February 2026 in “Frontiers in Medical Technology” Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.
February 2026 in “Clinical Cosmetic and Investigational Dermatology” Female pattern hair loss is linked to genetics, family history, and lifestyle factors.
January 2026 in “SKIN The Journal of Cutaneous Medicine” Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.
January 2026 in “Clinical Cosmetic and Investigational Dermatology” Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.
January 2026 in “Ankara Medical Journal” Pregnancy-related stress may cause hair loss in women in their third trimester.
December 2025 in “Ekonomia/Acta Universitatis Wratislaviensis. Ekonomia” Elderly demand for hair care services is rapidly increasing.
December 2025 in “Cureus” "Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.
Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.
GV-350 improves hair growth and quality of life in iron-deficient women without side effects.
November 2025 in “International Journal for Research in Applied Science and Engineering Technology” Herbal shampoos are popular for being safe, effective, and eco-friendly.
November 2025 in “Frontiers in Immunology” Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.
November 2025 in “Journal of Pharmaceutical Research International” Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.
November 2025 in “Journal of Cancer Research and Clinical Oncology” Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.
November 2025 in “Frontiers in Medicine” Baseline severity and relapse history affect alopecia areata treatment and recurrence.
November 2025 in “Frontiers in Medicine” The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.
October 2025 in “Scientific Reports” AR gene variations don't affect aging markers in men.
October 2025 in “International Journal of Innovative Research in Technology” Certain natural ingredients and lifestyle changes can help manage PCOS symptoms by balancing hormones and improving insulin sensitivity.
October 2025 in “Pakistan journal of urology.” Personalized, minimally invasive treatments improve urology outcomes.
October 2025 in “Cermin Dunia Kedokteran” Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.
October 2025 in “Frontiers in Medicine” The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.
September 2025 in “Universal library of medical and health sciences.” Permanent makeup can effectively restore lip shape and color after tissue loss, improving appearance and well-being.
September 2025 in “AYUSHDHARA” Ayurvedic treatment relieved a 5-year-old girl's scalp infection symptoms in two weeks.
September 2025 in “Cureus” GLP-1 agonists may help treat certain skin conditions.
September 2025 in “Journal of Ayurveda and Integrated Medical Sciences” Surgery and Ayurvedic treatments together effectively healed a scalp cyst without relapse.
September 2025 in “Cureus” GLP-1 receptor agonists may cause hair loss, but more research is needed.
September 2025 in “OBM Genetics” Early diagnosis and comprehensive management improve life quality for Netherton syndrome patients.
August 2025 in “Frontiers in Pharmacology” [6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.
Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.
The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.